News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Glucksmann Alexandra
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/06/2023 |
4
| Glucksmann Alexandra (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 3,486 shares
@ $0
Granted 17,892 options to buy
@ $19.72, valued at
$352.8k
|
|
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2020 |
4
| Glucksmann Alexandra (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 10,000 options to buy
@ $37.66, valued at
$376.6k
|
|
| 06/04/2019 |
4
| Glucksmann Alexandra (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 10,000 options to buy
@ $43.02, valued at
$430.2k
|
|
| 05/30/2018 |
4
| Glucksmann Alexandra (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 25,000 options to buy
@ $49.45, valued at
$1.2M
|
|
| 05/30/2018 |
3
| Glucksmann Alexandra (Director) has filed a Form 3 on REGENXBIO Inc. |
| 03/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/24/2016 |
4
| Glucksmann Alexandra (COO) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Sold 1,000 shares
@ $20, valued at
$20k
Exercised 1,000 options to buy
@ $0.65, valued at
$650 |
|
|
|